S100A4 and breast carcinoma: For instance, immunofluorescent staining of CAFs identified by their morphology shows that co-expression of FSP1 and αSMA occurs in 10.9% of the total CAF population in the 4T1 murine breast carcinoma model, compared to 43.5% in the Rip1Tag2 pancreatic tumor model [61].